We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more
Alzamend Neuro, Inc. (Nasdaq: ALZN) (βAlzamendβ), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimerβs disease (βAlzheimerβsβ), bipolar...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.069 | 17.6470588235 | 0.391 | 0.469 | 0.3707 | 44429 | 0.39493466 | CS |
4 | -0.11 | -19.298245614 | 0.57 | 0.578 | 0.3691 | 108445 | 0.47351004 | CS |
12 | -0.3962 | -46.2742349918 | 0.8562 | 0.8801 | 0.3691 | 84070 | 0.55448995 | CS |
26 | -0.49 | -51.5789473684 | 0.95 | 1.29 | 0.3691 | 67180 | 0.75018687 | CS |
52 | -7.055 | -93.878908849 | 7.515 | 8.1 | 0.3691 | 136439 | 2.61962571 | CS |
156 | -90.44 | -99.4939493949 | 90.9 | 124.2 | 0.3691 | 1120036 | 36.832213 | CS |
260 | -434.54 | -99.8942528736 | 435 | 503.25 | 0.3691 | 1150882 | 41.78104148 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions